Ratos AB ser. B (0KBQ)
London Exchange · UK · prices in SEK · close of 21 Oct 2026
Key indicators
| Last close | SEK 36.53 |
|---|---|
| 52-week range | 31.22 – 40.10 |
| Return, 1 month / 3 months | −4.2% / +0.7% |
| Return, 1 year / 3 years | −4.4% / +32.9% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 44 |
| Volatility (1 year) | 27.6% |
| Worst drawdown (1 year) | -21.2% |
| Average daily value traded | 0.99M SEK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Ratos is a Swedish investment company based in Stockholm that owns and develops mid-sized businesses. It invests in companies active in industry, construction, consumer goods and business services, often taking significant ownership positions and working with their management teams over the long term. Its portfolio companies operate in the Nordic region and beyond, serving business and consumer markets, while Ratos itself provides capital and industrial expertise to support their operations.
The shares are listed on the London Exchange in UK under the code 0KBQ, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Ratos AB ser. B (0KBQ) trades on the London Exchange in UK. It last closed at SEK 36.53 on 21 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 1,310 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 4.4% and over the last three months it rose 0.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 62 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.9% | ||
| From 52-week high | -8.9% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 0.7% | ||
| 6-month return | 7.9% | ||
| 12-month return, skipping the last month | -0.2% | ||
| Stability (higher is calmer) | 69 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 27.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.2% | ||
| Liquidity | 52 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.99M SEK | ||
| Zero-volume days | 6.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −2.2% |
|---|---|
| 1 month | −4.2% |
| 3 months | +0.7% |
| 6 months | +7.9% |
| 1 year | −4.4% |
| 3 years | +32.9% |
| 5 years | −20.7% |
Signals
| 50-day / 200-day average | 37.46 / 35.86 |
|---|---|
| Golden / death cross (60 days) | Golden, 36 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.90 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Mar 2025 | SEK 1.3500 |
| 27 Mar 2024 | SEK 1.2500 |
| 29 Mar 2023 | SEK 0.8400 |
| 23 Mar 2022 | SEK 1.2000 |
| 11 Mar 2021 | SEK 0.9500 |
| 23 Oct 2020 | SEK 0.6500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.